What does APOTHEEK ANN-SOPHIE LEROY do?

APOTHEEK ANN-SOPHIE LEROY is a pharmacy in Menen. Private Limited, started on 15 February 1996, 3 establishments.

What is the address of APOTHEEK ANN-SOPHIE LEROY?

The registered office of APOTHEEK ANN-SOPHIE LEROY is located at Ieperstraat 95, 8930 Menen.

Is APOTHEEK ANN-SOPHIE LEROY still active?

Yes. According to the CBE (29 October 2026) APOTHEEK ANN-SOPHIE LEROY is active, legal situation “Normale toestand”, started on 15 February 1996.

Is APOTHEEK ANN-SOPHIE LEROY registered on Peppol?

Yes, APOTHEEK ANN-SOPHIE LEROY is registered on the Peppol network with ID 0208:0457332432.

What is the enterprise number of APOTHEEK ANN-SOPHIE LEROY?

The enterprise number of APOTHEEK ANN-SOPHIE LEROY is BE0457332432.

When was APOTHEEK ANN-SOPHIE LEROY founded?

APOTHEEK ANN-SOPHIE LEROY was founded on 15 February 1996.

Who are the directors of APOTHEEK ANN-SOPHIE LEROY?

According to the 2025 annual accounts, the directors of APOTHEEK ANN-SOPHIE LEROY are: ANSOPHARMA.

Is APOTHEEK ANN-SOPHIE LEROY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 February 1996; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 3 establishments in the CBE.

How much profit did APOTHEEK ANN-SOPHIE LEROY make in 2025?

APOTHEEK ANN-SOPHIE LEROY posted a profit after taxes of € 371,237 in financial year 2025.

What is the revenue of APOTHEEK ANN-SOPHIE LEROY?

As a small company, APOTHEEK ANN-SOPHIE LEROY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 936,975.

How much does an employee at APOTHEEK ANN-SOPHIE LEROY earn?

The average wage cost per full-time employee at APOTHEEK ANN-SOPHIE LEROY was € 69,200 in 2025: staff costs of € 525,810 for 7.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK ANN-SOPHIE LEROY have?

According to the 2025 annual accounts, APOTHEEK ANN-SOPHIE LEROY has 7.6 full-time equivalents (FTE).

APOTHEEK ANN-SOPHIE LEROY (Private Limited) - Menen

Dossier APOTHEEK ANN-SOPHIE LEROY, printed on 29 October 2026 from databakkes.be/en/0457332432/apotheek-ann-sophie-leroy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK ANN-SOPHIE LEROY from Menen, company number BE0457332432, closed financial year 2025 with a result of € 371,237 after tax. For that financial year APOTHEEK ANN-SOPHIE LEROY recorded a gross margin of € 936,975 and equity of € 640,438. Compared with financial year 2024, the result moved from € 201,338 to € 371,237. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Growing

€ 640,438

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 371,237

▲ 84% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 122,642

▲ 41% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 370,000 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

7.6

▲ 2.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 525,810

▲ 50% vs 2024

€ 69,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,985

▼ 28% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 401,137

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 90,849

▲ 127% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 449,827 Gross margin 2022: € 449,827 First fiscal year in the series	€ 485,917 Gross margin 2023: € 485,917 ▲ 8% vs 2022 (€ 449,827) Favourable step	€ 607,967 Gross margin 2024: € 607,967 ▲ 25% vs 2023 (€ 485,917) Favourable step	€ 936,975 Gross margin 2025: € 936,975 ▲ 54% vs 2024 (€ 607,967) Favourable step	▲ 54%
Profit after taxes	€ 201,520 Profit after taxes 2022: € 201,520 First fiscal year in the series	€ 165,250 Profit after taxes 2023: € 165,250 ▼ 18% vs 2022 (€ 201,520) Unfavourable step	€ 201,338 Profit after taxes 2024: € 201,338 ▲ 22% vs 2023 (€ 165,250) Favourable step	€ 371,237 Profit after taxes 2025: € 371,237 ▲ 84% vs 2024 (€ 201,338) Favourable step	▲ 84%
Equity	€ 632,613 Equity 2022: € 632,613 First fiscal year in the series	€ 637,863 Equity 2023: € 637,863 ▲ 1% vs 2022 (€ 632,613) Favourable step	€ 639,201 Equity 2024: € 639,201 Unchanged (€ 637,863) Favourable step	€ 640,438 Equity 2025: € 640,438 Unchanged (€ 639,201) Favourable step
Total debts	€ 372,391 Total debts 2022: € 372,391 First fiscal year in the series	€ 470,452 Total debts 2023: € 470,452 ▲ 26% vs 2022 (€ 372,391) Unfavourable step	€ 671,090 Total debts 2024: € 671,090 ▲ 43% vs 2023 (€ 470,452) Unfavourable step	€ 871,281 Total debts 2025: € 871,281 ▲ 30% vs 2024 (€ 671,090) Unfavourable step	▲ 30%
Cash	€ 173,870 Cash 2022: € 173,870 First fiscal year in the series	€ 199,176 Cash 2023: € 199,176 ▲ 15% vs 2022 (€ 173,870) Favourable step	€ 87,189 Cash 2024: € 87,189 ▼ 56% vs 2023 (€ 199,176) Unfavourable step	€ 122,642 Cash 2025: € 122,642 ▲ 41% vs 2024 (€ 87,189) Favourable step	▲ 41%
Land & buildings	€ 66,211 Land & buildings 2022: € 66,211 First fiscal year in the series	€ 61,993 Land & buildings 2023: € 61,993 ▼ 6% vs 2022 (€ 66,211) Unchanged	€ 55,707 Land & buildings 2024: € 55,707 ▼ 10% vs 2023 (€ 61,993) Unchanged	€ 49,421 Land & buildings 2025: € 49,421 ▼ 11% vs 2024 (€ 55,707) Unchanged	▼ 11%
Retained profit	€ 614,063 Retained profit 2022: € 614,063 First fiscal year in the series	€ 619,313 Retained profit 2023: € 619,313 ▲ 1% vs 2022 (€ 614,063) Favourable step	€ 620,651 Retained profit 2024: € 620,651 Unchanged (€ 619,313) Favourable step	€ 621,888 Retained profit 2025: € 621,888 Unchanged (€ 620,651) Favourable step
Dividend	€ 200,000 Dividend 2022: € 200,000 First fiscal year in the series	€ 160,000 Dividend 2023: € 160,000 ▼ 20% vs 2022 (€ 200,000) Unchanged	€ 200,000 Dividend 2024: € 200,000 ▲ 25% vs 2023 (€ 160,000) Unchanged	€ 370,000 Dividend 2025: € 370,000 ▲ 85% vs 2024 (€ 200,000) Unchanged	▲ 85%
Balance sheet total	€ 1,005,004 Balance sheet total 2022: € 1,005,004 First fiscal year in the series	€ 1,108,315 Balance sheet total 2023: € 1,108,315 ▲ 10% vs 2022 (€ 1,005,004) Unchanged	€ 1,310,291 Balance sheet total 2024: € 1,310,291 ▲ 18% vs 2023 (€ 1,108,315) Unchanged	€ 1,511,718 Balance sheet total 2025: € 1,511,718 ▲ 15% vs 2024 (€ 1,310,291) Unchanged	▲ 15%
Employees (FTE)	4 Employees (FTE) 2022: 4 First fiscal year in the series	4.3 Employees (FTE) 2023: 4.3 ▲ 0.3 vs 2022 (4) Unchanged	5.4 Employees (FTE) 2024: 5.4 ▲ 1.1 vs 2023 (4.3) Unchanged	7.6 Employees (FTE) 2025: 7.6 ▲ 2.2 vs 2024 (5.4) Unchanged	▲ 2.2

Key figures of APOTHEEK ANN-SOPHIE LEROY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK ANN-SOPHIE LEROY?

What happened at APOTHEEK ANN-SOPHIE LEROY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 371,237 (▲ 84% vs 2024). Source: NBB ↗
Sep 1, 2024 New establishment in Wervik. KBO
Nov 1, 2017 New establishment in Wervik. KBO
2017 ANSOPHARMA became a director. NBB
Sep 12, 1996 New establishment in Menen. KBO
Feb 15, 1996 Start of the company according to the CBE. KBO

In short

From € 201,520 profit in 2022 to € 371,237 profit in 2025.

Paid € 5,429 in corporate taxes since 2022.

Best year ever: 2025, with € 371,237 profit.

On average € 123,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ANSOPHARMA

APOTHEEK ANN-SOPHIE LEROY

APOTHEEK VALCKE

Apotheek Leroy Geluwe

Behind APOTHEEK ANN-SOPHIE LEROY is ANSOPHARMA. ANSOPHARMA is also behind APOTHEEK VALCKE and Apotheek Leroy Geluwe.

Directors

According to the 2025 annual accounts

ANSOPHARMA

Director · represented by Leroy Ann-Sophie

Also active at: APOTHEEK VALCKE, Apotheek Leroy Geluwe

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Ieperstraat 95

8930 Menen

2.370.779.077

Beselarestraat 28

8940 Wervik

Active since 1 November 2017

2.370.779.176

Vrouwstraat 5

8940 Wervik

Active since 1 September 2024

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

PROREDAR

€ 176,715 gross margin · 2025

DEMA

€ 1.3 million gross margin · 2025

Ansopharma same network

GROEP LEROY

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0457.332.432

VAT number

BE 0457.332.432

Registered office

Ieperstraat 95, 8930 Menen

Names & denominations

APOTHEEK ANN-SOPHIE LEROY

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

15 February 1996

Peppol

Active · Active since 25 Apr 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in drogisterijartikelen en onderhoudsproducten

Gespecialiseerde detailhandel in drogisterijartikelen en onderhoudsproducten

Detailhandel in drogisterijartikelen en onderhoudsproducten in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK ANN-SOPHIE LEROY

Financials

What happened to APOTHEEK ANN-SOPHIE LEROY?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions